Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2008
10/23/2008US20080261818 Measuring the expression of three or more specific target molecules in combination and correlating positive expression of the combination with an identification of the cell as a pancreatic cancer cell; using immunocytochemistry analysis
10/23/2008US20080261817 Methods for Analyzing Global Regulation of Coding and Non-Coding RNA Transcripts Involving Low Molecular Weight RNAs
10/23/2008US20080261815 Using m-tyrosine compounds or the salts of m-tyrosine compounds from Festuca spp. for inhibiting weed growth and enhancing growth of non-weed plants; environmentally acceptable means of weed control
10/23/2008US20080261318 Signalling Compounds For Use In Methods Of Detecting Hydrogen Peroxide
10/23/2008US20080261311 Translation systems with orthogonal aminoacyl tRNA synthetase; membrane proteins
10/23/2008US20080261302 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease
10/23/2008US20080261277 Circularly permuted RNA molecule carrying a stabilized biologically active RNA; antisense RNA; gene expression inhbition; ribozyme
10/23/2008US20080261275 Recovering and replicating RNA sequences from preferential tissues; organ specific RNA libraries
10/23/2008US20080261264 Dissolving protease peptone, microbiological peptone, yeast extract, sodium bisulphite and ferric ammonium citrate in deonized water; sterilising and cooling, then adding cycloserine and disodic salt of 4-methylumbelliferyl phosphate dissolved in deionized water and sterilised by filtration
10/23/2008US20080261263 Using selected ion flow tube-mass spectrometry to identify bacteria in blood and/or urine; monitoring efficacy of microbiocides; drug screening
10/23/2008US20080261262 Lysis/Resealing Process and Device for Incorporating an Active Ingredient, in Particular Asparaginase or Inositol Hexaphosphate, in Erythrocytes
10/23/2008US20080261261 Using biosensor which monitors platelet aggregation as evaluative tool in determining concentration of blood taken from patients
10/23/2008US20080261260 Using actin binding protein expression as evaluative tool in diagnosing/prediciting gram-positive bacterial infection
10/23/2008US20080261259 Nutrient broth for propagation and maintanence of animal cells for use in treatment of baldness
10/23/2008US20080261258 Using proteomic signature of antigen presenting cell as evaluative tool in diagnosing/predicting metabolic disorders
10/23/2008US20080261257 Fluorescent Proteins and Related Methods and Compounds
10/23/2008US20080261256 Methods of assaying receptor activity and constructs useful in such methods
10/23/2008US20080261255 Reporter molecule comprising anilino-naphthalene sulfonate and ruthenium complex for use in determining concentration of protein in solutions
10/23/2008US20080261254 Procedure for the determination of the reaction lag phase in an analyte-dependent reaction
10/23/2008US20080261250 Detecting presence of HDL oxidation product such as nitrotyrosine; ELISA; kits
10/23/2008US20080261246 Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer
10/23/2008US20080261241 Targeted ubiquitination of proteins and screening methods using a new class of ubiquitin ligase proteins
10/23/2008US20080261240 Method
10/23/2008US20080261238 Method for Differentiation of Factor XIII Deficiency States in Relation to Fibrinogen Deficiency States Using Thrombelastographic Techniques
10/23/2008US20080261236 FGF21 upregulates expression of GLUT-1 in a beta Klotho-dependent manner
10/23/2008US20080261231 Nucleotide sequences coding angiotensinogen (AGT) gene for use as evaluative tool in diagnosing pancreatic disorders; disease screening through genomic variance
10/23/2008US20080261230 Fermentive production of isobutanol using highly active ketol-acid reductoisomerase enzymes
10/23/2008US20080261229 Using nucleic acid specific stain to screen for presence of mold
10/23/2008US20080261228 Using prostate cancer antigen (PCA) expression as evaluative tool in diagnosis/prognosis of cancer
10/23/2008US20080261227 Kinetic Pcr Assay for Quantification of Gene Amplification on Chromosome 17
10/23/2008US20080261226 Biomarkers of neurodegenerative disease
10/23/2008US20080261225 Using guard DNA (single stranded DNA) as tool in detection of preferential gene sequences; aptamer beacon engineering; biosensors
10/23/2008US20080261224 PGC-1Beta, A Novel PGC-1 Homologue and Uses Therefor
10/23/2008US20080261223 Aldo-keto reductase specific immunoglobulin for use in diagnosis, classification and imaging of cell proliferative disorders
10/23/2008US20080261222 Ribosomal DNA specific oligonucleotide for use in classification of preferential microorganisms
10/23/2008US20080261221 Automated vntr genotyping method
10/23/2008US20080261220 High-throughput oligonucleotide production system comprising oligonucleotide synthesizer and multiwell components
10/23/2008US20080261219 Nucleotide sequence probes for use in detecting mutation in epidermal growth factor receptor (EGFR) gene; diagnosing/prognosing cell proliferative disorders
10/23/2008US20080261218 Detection of Biomarkers for Neuropsychiatric Disorders
10/23/2008US20080261217 Using CpG sequence methylation patterning as diagnostic/prognostic tool in detection of cell proliferative disorders
10/23/2008US20080261216 Using human endogenous retrovirus (HERVs) expression as evaluative tool in diagnosis/prognosis of cell proliferative disorders
10/23/2008US20080261215 Using allergen mediator expression as evaluative tool in prediciting allergic response to birch and/or grass pollens, mites and bee allergens; immunotherapy
10/23/2008US20080261214 Using cleavage polymorphism in sterol regulator element binding proteins (SREBP) gene as evaluative tool in predicting/diagnosing clinical outcomes associated with viral infection, nervous system and cholesterol disorders
10/23/2008US20080261213 Assay
10/23/2008US20080261212 Using lipoprotein lipase (LPL) and/or a disintegrin and metalloproteinase 29 (ADAM29) expression as evaluative indicator of cell proliferative and lipoprotein metabolism disorders
10/23/2008US20080261211 Using polymorphic variation in complement cascade genes as evaluative tool in prognosis/diagnosis of vision defects
10/23/2008US20080261210 Using colorimetric analysis to determine plasma homocysteine concentration in blood
10/23/2008US20080261209 Electrophoretic Separation Method for Analyzing Gene Expression
10/23/2008US20080261208 For DNA sequencing
10/23/2008US20080261207 Exposing cell to cytotoxic/cytoststic agents and using tumor marker expression to evaluate sensitivity to abnormal cell proliferation
10/23/2008US20080261206 Microarray comprising bacterial-specific oligonucleotides for detection and classification of microorganisms
10/23/2008US20080261205 Method for the Simultaneous Determination of Blood Group and Platelet Antigen Genotypes
10/23/2008US20080261204 Using coded probes to quantify absolute or relative number of molecules pool after DNA amplification
10/23/2008US20080261203 Detection of Epstein-Barr Virus
10/23/2008US20080261202 Hydrogen ion concentration sensitive probe for use as screening tool in biopolymer detection
10/23/2008US20080261201 Methods and compounds to alter virus infection
10/23/2008US20080261200 Detection of Nucleic Acid Mutations
10/23/2008US20080261199 Rapid detection processes and related compositions
10/23/2008US20080261198 Hemagglutinin (HA) and/or neuraminidase (NA) specific primer for use in screening for influenza infection
10/23/2008US20080261197 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection
10/23/2008US20080261196 Naphthalene diimide-zn(ii) complex having selectivity for pyrophosphate, preparation method thereof and detecting method of pyrophosphate using the same
10/23/2008US20080260858 Universal Procoagulant
10/23/2008US20080260829 Bone morphogenic proteins (bmp); cell adhesion modulating agent; peptidomimetics of cyclic peptides comprising classical cadherin cell adhesion recognition (CAR) sequences; modulate cell adhesion and improve drug delivery
10/23/2008US20080260768 Streptococcus pneumoniae proteins and nucleic acid molecules
10/23/2008US20080260766 Epitopes, combined epitopes, use of epitopes or their combination, composition, uses of the composition, anti-HIV-1 prophylactic vaccines, therapeutic vaccines, method for the identification of epitopes and methods for treatment and prevention
10/23/2008US20080260764 Variation in viral replication peptide as evaluative tool in predicting virulence in emerging influenza strains
10/23/2008US20080260761 Compositions, Splice Variants and Methods Relating to Cancer Specific Genes and Proteins
10/23/2008US20080260750 Polynucleotides Encoding Acetylcholine-Gated Chloride Channel Subunits of Caenorhabditis Elegans
10/23/2008US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood
10/23/2008US20080260744 Using neuronal membrane protein receptor as screening tool in identifying modulators for treatment of brain disorders
10/23/2008US20080260743 Means and Methods for Detecting Methylated Dna
10/23/2008US20080260742 Preventives/Remedies for Cancer
10/23/2008US20080260739 Use of Anti-Mortalin 2 Antibody and Functional Nucleic Acid for Cancer Therapies
10/23/2008US20080260726 Using cathepsin C gene expression as evaluative tool in identifying modulators for prevention and treatment of inflammatory or obstructive diseases of the respiratory system
10/23/2008US20080260724 Using pattern recognition receptor specific immunoglobulin to target and treat fungal infection
10/23/2008US20080260721 Nucleotide sequences coding regulatory-associated protein of mTOR (Raptor) protein for use in identifying modulators for prevention and treatment of cancer and diabetes
10/23/2008US20080260720 Systems and Methods for Inhibiting Metastasis
10/23/2008US20080260719 EDG: Modulators of lymphocyte activation and migration
10/23/2008US20080260718 Phospholipase C Gamma Modulation and Uses Thereof for Management of Pain and Nociception
10/23/2008US20080260717 Methods for Reducing Seizure-Induced Neuronal Damage
10/23/2008US20080260713 Neukinase, A Downstream protein of neuregulin
10/23/2008US20080260698 Chimeric sindbis-western equine encephalitis virus and uses thereof
10/23/2008US20080260687 Identifying modulators which interfere with interleukin-6 and interleukin-6 receptor binding; antitumor agents; treating cell proliferative disorders
10/23/2008US20080260686 Methods of using il-31 to treat airway hyper-responsiveness and asthma
10/23/2008US20080260647 Determination concentration of halophor; generation a fluorescent signal; accurate three-dimensional reconstructions
10/23/2008US20080260637 Methods of Detecting Prostate Cancer
10/23/2008US20080260588 Hydrophilic polymer bonded at surface to hydrophobic polymer
10/23/2008US20080257728 Biosensor
10/23/2008US20080257727 Extracellular potential sensing element, device for measuring extracellular potential, apparatus for measuring extracellular potential and method of measuring extracellular potential by using the same
10/23/2008US20080257726 Extracellular potential sensing element, device for measuring extracellular potential, apparatus for measuring extracellular potential and method of measuring extracellular potential by using the same
10/23/2008US20080257725 Biosensor
10/23/2008DE102007018833A1 Molecular-biological processing unit for detection, analysis of genomes, for producing e.g. synthetic nucleic acids, comprises device for in-situ-synthesis of arrays of receptors
10/23/2008DE102007011913A1 Fluoreszenz-basiertes Assay zum Erkennen von Verbindungen zum Modulieren des Natrium-Calcium-Austauschers (NCX) im "Vorwärtsmodus" Fluorescence-based assay for identifying compounds for modulating the sodium-calcium exchanger (NCX) in the "forward mode"
10/23/2008CA2688693A1 Interferons of rhesus and cynomolgus origin and uses thereof
10/23/2008CA2684357A1 Microbial population analysis
10/23/2008CA2683840A1 Periodic acid-schiff staining with detection in the infrared range
10/23/2008CA2683815A1 Involvement of lipid kinase, and signal transduction pathway comprising said lipid kinase, in resistance to her2-targeting therapy
10/23/2008CA2683685A1 Method of determining a chemotherapeutic regime and survival expectancy for non small cell lung cancer based on egfr/csf-1/ca ix expression
10/23/2008CA2683585A1 Alleles and polymorphisms predictive of responsiveness to biologic therapy in psoriasis
10/23/2008CA2683562A1 Sirtuin based methods and compositions for treating .beta.-catenin-related conditions